ロード中...
An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib
BACKGROUNDS/AIMS: Vitamin K may plays a role in controlling hepatocellular carcinoma (HCC) cell growth. In this study, we intended to present 5-year experience of 72 patients receiving oral vitamin K with or without sorafenib. Its end-point was to evaluate the safety of combination therapy using sor...
保存先:
| 出版年: | Korean J Hepatobiliary Pancreat Surg |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Association of Hepato-Biliary-Pancreatic Surgery
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494089/ https://ncbi.nlm.nih.gov/pubmed/26155269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/kjhbps.2015.19.1.1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|